Soorena Khorshidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Soorena Khorshidi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Roozbeh Narimani Javid
Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran
5 shared publications Alireza Arzhangzadeh
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
3 shared publications- Alireza Arzhangzadeh
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
3 shared publications Salma Nozhat
Department of Cardiology, Shiraz University of Medical Sciences, Shiraz, Iran
3 shared publications- Sasan Shafiei
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
3 shared publications Ahmad Ali Amirghofran
Department of Cardiac Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Aorta-sparing total arterial redo-CABG using a recycled patent LIMA: a consecutive 24-patient series with midterm clinical and computed tomographic outcomes
Background: Redo coronary artery bypass grafting (Redo-CABG) poses significant challenges due to complex coronary anatomy and limited conduit availability. In patients with a previously patent left internal mammary artery (LIMA), reusing it as an inflow source for total arterial revascularization (TAR) may offer a durable, stroke-sparing strategy. This study evaluated the safety and midterm outcomes of reusing a patent LIMA as an inflow source in Redo-CABG. Methods: This retrospective case series included 24 patients who underwent Redo-CABG at Faghihi and Dena Hospitals (Shiraz University of Medical Sciences) between March 2015 and October 2023. Consecutive patients were included to minimize selection bias. All patients had a patent LIMA confirmed by angiography or computed tomography angiography (CTA). Arterial grafts (right internal mammary and/or radial artery) were anastomosed to the patent LIMA to achieve complete TAR. Outcomes included perioperative complications, graft patency on CTA, and midterm major adverse cardiac or cerebrovascular events (MACCE). Results: All patients achieved complete TAR with no hospital or 30-day mortality. One patient required reoperation for bleeding. Mean postoperative ejection fraction was 44.5 ± 4.6%, and mean ICU stay was 3.1 ± 0.9 days. Early postoperative CT angiography (at 3 months) and midterm follow-up imaging (median 3.5 years; completed in a subgroup of 12 patients) demonstrated complete graft patency in all evaluated conduits, with no recorded MACCE. Conclusions: Reusing a patent LIMA as an inflow source for total arterial grafting in Redo-CABG appears to be a feasible and safe alternative for high-risk patients with limited conduit options. This approach minimizes extensive aortic manipulation, potentially offering a theoretical advantage in minimizing neurological risks. However, the retrospective, single-center design and small sample size preclude definitive conclusions regarding superiority, warranting further comparative evaluation in larger multicenter studies.
- 16 July 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessAorta-sparing total arterial redo-CABG using a recycled patent LIMA: a consecutive 24-patient series with midterm clinical and computed tomographic outcomes
Background: Redo coronary artery bypass grafting (Redo-CABG) poses significant challenges due to complex coronary anatomy and limited conduit availability. In patients with a previously patent left internal mammary artery (LIMA), reusing it as an inflow source for total arterial revascularization (TAR) may offer a durable, stroke-sparing strategy. This study evaluated the safety and midterm outcomes of reusing a patent LIMA as an inflow source in Redo-CABG. Methods: This retrospective case series included 24 patients who underwent Redo-CABG at Faghihi and Dena Hospitals (Shiraz University of Medical Sciences) between March 2015 and October 2023. Consecutive patients were included to minimize selection bias. All patients had a patent LIMA confirmed by angiography or computed tomography angiography (CTA). Arterial grafts (right internal mammary and/or radial artery) were anastomosed to the patent LIMA to achieve complete TAR. Outcomes included perioperative complications, graft patency on CTA, and midterm major adverse cardiac or cerebrovascular events (MACCE). Results: All patients achieved complete TAR with no hospital or 30-day mortality. One patient required reoperation for bleeding. Mean postoperative ejection fraction was 44.5 ± 4.6%, and mean ICU stay was 3.1 ± 0.9 days. Early postoperative CT angiography (at 3 months) and midterm follow-up imaging (median 3.5 years; completed in a subgroup of 12 patients) demonstrated complete graft patency in all evaluated conduits, with no recorded MACCE. Conclusions: Reusing a patent LIMA as an inflow source for total arterial grafting in Redo-CABG appears to be a feasible and safe alternative for high-risk patients with limited conduit options. This approach minimizes extensive aortic manipulation, potentially offering a theoretical advantage in minimizing neurological risks. However, the retrospective, single-center design and small sample size preclude definitive conclusions regarding superiority, warranting further comparative evaluation in larger multicenter studies.
- Open Access
- 28 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12) , e71533
Right Internal Mammary Artery Perforation and Large Mediastinal Hematoma Formation as a Complication of Radial Access Coronary Angiography: A Case Report
Perforation of the right internal mammary artery (RIMA) is an extremely rare vascular complication associated with the transradial approach (TRA) to coronary angiography. A 75‐year‐old woman presented with weakness. ECG revealed atrial fibrillation with long pauses. Echocardiography showed severe left ventricular (LV) systolic dysfunction (LVEF: 20%). During coronary angiography, an unintended passage of a hydrophilic wire into the RIMA caused tissue staining indicative of severe spasm without perforation. The patient was initially managed conservatively, but then she experienced a significant drop in hemoglobin. Subsequent CT angiography revealed a mediastinal hematoma. The patient was emergently transferred to the catheterization laboratory, where angiography confirmed RIMA perforation with dye extravasation. Despite the unsuccessful balloon tamponade, a 2.5 × 21 mm covered stent was deployed, successfully sealing the perforation. This case is distinctive as one of the very few reported RIMA perforations complicating TRA coronary angiography. It emphasizes the importance of vigilance even when early angiography shows no clear perforation and highlights covered stenting as a life‐saving option when balloon tamponade is unsuccessful. Knowing the possible complications of the TRA, specifically during hydrophilic guidewire maneuvers, empowers us to recognize and manage these complications promptly.
- 28 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12) , e71533
Open AccessRight Internal Mammary Artery Perforation and Large Mediastinal Hematoma Formation as a Complication of Radial Access Coronary Angiography: A Case Report
Perforation of the right internal mammary artery (RIMA) is an extremely rare vascular complication associated with the transradial approach (TRA) to coronary angiography. A 75‐year‐old woman presented with weakness. ECG revealed atrial fibrillation with long pauses. Echocardiography showed severe left ventricular (LV) systolic dysfunction (LVEF: 20%). During coronary angiography, an unintended passage of a hydrophilic wire into the RIMA caused tissue staining indicative of severe spasm without perforation. The patient was initially managed conservatively, but then she experienced a significant drop in hemoglobin. Subsequent CT angiography revealed a mediastinal hematoma. The patient was emergently transferred to the catheterization laboratory, where angiography confirmed RIMA perforation with dye extravasation. Despite the unsuccessful balloon tamponade, a 2.5 × 21 mm covered stent was deployed, successfully sealing the perforation. This case is distinctive as one of the very few reported RIMA perforations complicating TRA coronary angiography. It emphasizes the importance of vigilance even when early angiography shows no clear perforation and highlights covered stenting as a life‐saving option when balloon tamponade is unsuccessful. Knowing the possible complications of the TRA, specifically during hydrophilic guidewire maneuvers, empowers us to recognize and manage these complications promptly.
- Open Access
- 9 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11)
The Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent
This case highlights that severe hypokalemia can mimic the ECG findings associated with left main coronary artery disease. Early recognition and appropriate correction of electrolyte disturbances are essential in managing such presentations and avoiding misdiagnosis and unnecessary invasive procedures.
- 9 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11)
Open AccessThe Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent
This case highlights that severe hypokalemia can mimic the ECG findings associated with left main coronary artery disease. Early recognition and appropriate correction of electrolyte disturbances are essential in managing such presentations and avoiding misdiagnosis and unnecessary invasive procedures.
- Open Access
- 15 September 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Tricuspid Valve Replacement Using the Right Atrial Appendage Valve: Techniques and 1-Year Results
Objectives: When tricuspid valve repair is unfeasible due to extensive damage or a complex congenital malformation, surgeons consider tricuspid valve replacement (TVR). However, it is still controversial and challenging to choose the best substitute. We aimed to introduce the innovative intraoperatively valve construction using the native right atrial appendage (RAA) tissue for TVR and investigate the short-term outcomes. Methods: This study recruited paediatric and adult patients with unrepairable severe tricuspid regurgitation (TR) who needed TVR. The patient’s RAA tissue was harvested and used to reconstruct a native bileaflet valve during surgery. Transthoracic echocardiography was conducted before operation, 6, and 12 months after surgery. Results: The procedure was successfully executed on 3 patients with valve destruction as a result of infective endocarditis, and 3 patients who had severe TR due to congenital anomalies. There was no mortality or related morbidity. All the constructed valves had proper function with no complications after the surgery. Follow-up echocardiographic studies showed stable and satisfactory valve function with no regurgitation or significant stenosis. Conclusions: The novel tricuspid valve operation using native RAA tissue demonstrates promising short-term results. Further studies with larger cohorts and longer follow-ups are required to confirm the technique’s reliability and long-term effectiveness.
- 15 September 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Open AccessTricuspid Valve Replacement Using the Right Atrial Appendage Valve: Techniques and 1-Year Results
Objectives: When tricuspid valve repair is unfeasible due to extensive damage or a complex congenital malformation, surgeons consider tricuspid valve replacement (TVR). However, it is still controversial and challenging to choose the best substitute. We aimed to introduce the innovative intraoperatively valve construction using the native right atrial appendage (RAA) tissue for TVR and investigate the short-term outcomes. Methods: This study recruited paediatric and adult patients with unrepairable severe tricuspid regurgitation (TR) who needed TVR. The patient’s RAA tissue was harvested and used to reconstruct a native bileaflet valve during surgery. Transthoracic echocardiography was conducted before operation, 6, and 12 months after surgery. Results: The procedure was successfully executed on 3 patients with valve destruction as a result of infective endocarditis, and 3 patients who had severe TR due to congenital anomalies. There was no mortality or related morbidity. All the constructed valves had proper function with no complications after the surgery. Follow-up echocardiographic studies showed stable and satisfactory valve function with no regurgitation or significant stenosis. Conclusions: The novel tricuspid valve operation using native RAA tissue demonstrates promising short-term results. Further studies with larger cohorts and longer follow-ups are required to confirm the technique’s reliability and long-term effectiveness.
- Open Access
- 8 November 2024
- Published by Wiley
The Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent
- 8 November 2024
- Published by Wiley
Open AccessThe Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent
- Open Access
- 25 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e8908
Clinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review
Key Clinical Message: Cor triatriatum is a rare congenital heart abnormality in which a membrane separates the left atrium (LA; sinister) or the right atrium (dexter) into two compartments. It is also a long‐forgotten cause of atrial fibrillation (AF) and substantially higher rates of blood stagnation, particularly proximal to the additional septum in the LA. In this case report, we faced a CHA2DS2‐VASc score of 1 in patients with non‐valvular AF due to Cor triatriatum sinister (CTS). The decision to start anticoagulants in this particular case was controversial, so we reviewed the literature to assess and address it. We present our case and discuss the indication of anticoagulants in this unique clinical scenario, accompanied by a literature review. Facing this dilemma of starting anticoagulants in special cases of CTS and AF should be individualized and need more investigation. However, till this moment, based on similar reports, it seems to be rational to consider CTS Per se as an additional risk stratification marker beyond the CHA2DS2‐VASc score start anticoagulant until the surgical resection. Considering CTS as the sole indication of anticoagulant in patients with normal sinus rhythm is a complex matter that needs further investigation.
- 25 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e8908
Open AccessClinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review
Key Clinical Message: Cor triatriatum is a rare congenital heart abnormality in which a membrane separates the left atrium (LA; sinister) or the right atrium (dexter) into two compartments. It is also a long‐forgotten cause of atrial fibrillation (AF) and substantially higher rates of blood stagnation, particularly proximal to the additional septum in the LA. In this case report, we faced a CHA2DS2‐VASc score of 1 in patients with non‐valvular AF due to Cor triatriatum sinister (CTS). The decision to start anticoagulants in this particular case was controversial, so we reviewed the literature to assess and address it. We present our case and discuss the indication of anticoagulants in this unique clinical scenario, accompanied by a literature review. Facing this dilemma of starting anticoagulants in special cases of CTS and AF should be individualized and need more investigation. However, till this moment, based on similar reports, it seems to be rational to consider CTS Per se as an additional risk stratification marker beyond the CHA2DS2‐VASc score start anticoagulant until the surgical resection. Considering CTS as the sole indication of anticoagulant in patients with normal sinus rhythm is a complex matter that needs further investigation.
- Open Access
- 5 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (6) , e8916
Metastatic right atrial mass in the presence of atrial septal defect: A rare clinical coincidence
Key Clinical Message: The key takeaway from this clinical scenario is to choose the most appropriate and reasonable treatment plan when dealing with a patient who has atrial septal defect (ASD) and concurrent atrial and mediastinal masses. In such cases, a heart‐oncology team should make the therapeutic decision. Right atrial masses are not pretty rare and might be a diagnostic challenge. Thrombosis, tumors, and vegetations are primary differential diagnoses. Workup for these masses usually includes multimodality imaging and biopsy in selected cases. We report a case of a 37‐year‐old lady who presented with cough, dyspnea, and head and neck swelling after a cesarean section. Echocardiography revealed a right atrial mass accompanied by a secundum type atrial septal defect (ASD). Pulmonary CT Angiography was performed, in which a lobulated mass in the anterior mediastinum was detected, and a heart‐oncology team made the therapeutic decision. The patient was scheduled for surgical ASD closure and concomitant tissue biopsy. The pathology results were in favor of poorly differentiated germ cell tumors, and chemotherapy was started following the surgery. After two sessions of chemotherapy, the tumor did not respond to the primary regimen. Thus, an updated regimen was initiated. Compliance with the updated regimen was acceptable, and the patient is currently under treatment and follow‐up.
- 5 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (6) , e8916
Open AccessMetastatic right atrial mass in the presence of atrial septal defect: A rare clinical coincidence
Key Clinical Message: The key takeaway from this clinical scenario is to choose the most appropriate and reasonable treatment plan when dealing with a patient who has atrial septal defect (ASD) and concurrent atrial and mediastinal masses. In such cases, a heart‐oncology team should make the therapeutic decision. Right atrial masses are not pretty rare and might be a diagnostic challenge. Thrombosis, tumors, and vegetations are primary differential diagnoses. Workup for these masses usually includes multimodality imaging and biopsy in selected cases. We report a case of a 37‐year‐old lady who presented with cough, dyspnea, and head and neck swelling after a cesarean section. Echocardiography revealed a right atrial mass accompanied by a secundum type atrial septal defect (ASD). Pulmonary CT Angiography was performed, in which a lobulated mass in the anterior mediastinum was detected, and a heart‐oncology team made the therapeutic decision. The patient was scheduled for surgical ASD closure and concomitant tissue biopsy. The pathology results were in favor of poorly differentiated germ cell tumors, and chemotherapy was started following the surgery. After two sessions of chemotherapy, the tumor did not respond to the primary regimen. Thus, an updated regimen was initiated. Compliance with the updated regimen was acceptable, and the patient is currently under treatment and follow‐up.